-
Posted by
Two Blokes Mon at 11:15 PM -
Filed in
Stock
-
3 views
Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces that, further to its press releases of March 28, 2025 and May 2, 2025, it has closed its non-brokered private placement (the "Offering"). Pursuant to the Offering, the Company issued an aggregate of 8,150,000 units (the "Units") at a price of $0.125 per Unit for aggregate gross proceeds of $1,018,750 (the "Offering").
